168 related articles for article (PubMed ID: 33743773)
1. NTCP modeling and dose-volume correlations for acute xerostomia and dry eye after whole brain radiation.
Mavroidis P; Pearlstein KA; Moon DH; Xu V; Royce TJ; Weiner AA; Shen CJ; Marks LB; Chera BS; Das SK; Wang K
Radiat Oncol; 2021 Mar; 16(1):56. PubMed ID: 33743773
[TBL] [Abstract][Full Text] [Related]
2. Prospective Assessment of Patient-Reported Dry Eye Syndrome After Whole Brain Radiation.
Wang K; Tobillo R; Mavroidis P; Pappafotis R; Pearlstein KA; Moon DH; Mahbooba ZM; Deal AM; Holmes JA; Sheets NC; Kasibhatla MS; Pacholke HD; Royce TJ; Weiner AA; Shen CJ; Zagar TM; Marks LB; Chera BS
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):765-772. PubMed ID: 31351194
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Risk of Xerostomia After Whole-Brain Radiation Therapy and Association With Parotid Dose.
Wang K; Pearlstein KA; Moon DH; Mahbooba ZM; Deal AM; Wang Y; Sutton SR; Motley BB; Judy GD; Holmes JA; Sheets NC; Kasibhatla MS; Pacholke HD; Shen CJ; Zagar TM; Marks LB; Chera BS
JAMA Oncol; 2019 Feb; 5(2):221-228. PubMed ID: 30489607
[TBL] [Abstract][Full Text] [Related]
4. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
5. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
Semenenko VA; Li XA
Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain Irradiation Field Design: A Comparison of Parotid Dose.
Wu CC; Wuu YR; Jani A; Saraf A; Tai CH; Lapa ME; Andrew JIS; Tiwari A; Saadatmand HJ; Isaacson SR; Cheng SK; Wang TJC
Med Dosim; 2017 Summer; 42(2):145-149. PubMed ID: 28479012
[TBL] [Abstract][Full Text] [Related]
7. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
Marzi S; Iaccarino G; Pasciuti K; Soriani A; Benassi M; Arcangeli G; Giovinazzo G; Benassi M; Marucci L
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1252-9. PubMed ID: 19251097
[TBL] [Abstract][Full Text] [Related]
8. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
Amosson CM; Teh BS; Van TJ; Uy N; Huang E; Mai WY; Frolov A; Woo SY; Chiu JK; Carpenter LS; Lu HH; Grant WH; Butler EB
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):136-44. PubMed ID: 12694832
[TBL] [Abstract][Full Text] [Related]
10. Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessments.
Lee TF; Chao PJ; Wang HY; Hsu HC; Chang P; Chen WC
BMC Cancer; 2012 Dec; 12():567. PubMed ID: 23206972
[TBL] [Abstract][Full Text] [Related]
11. Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?
Cella L; Palma G; Deasy JO; Oh JH; Liuzzi R; D'Avino V; Conson M; Pugliese N; Picardi M; Salvatore M; Pacelli R
PLoS One; 2014; 9(10):e111753. PubMed ID: 25360627
[TBL] [Abstract][Full Text] [Related]
12. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
[TBL] [Abstract][Full Text] [Related]
13. Parotid gland mean dose as a xerostomia predictor in low-dose domains.
Gabryś HS; Buettner F; Sterzing F; Hauswald H; Bangert M
Acta Oncol; 2017 Sep; 56(9):1197-1203. PubMed ID: 28502238
[TBL] [Abstract][Full Text] [Related]
14. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
[TBL] [Abstract][Full Text] [Related]
15. Risk of dry eye syndrome in patients treated with whole-brain radiotherapy.
Nanda T; Wu CC; Campbell AA; Bathras RM; Jani A; Kazim M; Wang TJC
Med Dosim; 2017 Winter; 42(4):357-362. PubMed ID: 28784430
[TBL] [Abstract][Full Text] [Related]
16. Fitting NTCP models to bladder doses and acute urinary symptoms during post-prostatectomy radiotherapy.
Mavroidis P; Pearlstein KA; Dooley J; Sun J; Saripalli S; Das SK; Wang AZ; Chen RC
Radiat Oncol; 2018 Feb; 13(1):17. PubMed ID: 29394931
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy.
Lee TF; Fang FM
Radiother Oncol; 2013 Mar; 106(3):352-8. PubMed ID: 23333019
[TBL] [Abstract][Full Text] [Related]
18. Parotid gland function after radiotherapy: the combined michigan and utrecht experience.
Dijkema T; Raaijmakers CP; Ten Haken RK; Roesink JM; Braam PM; Houweling AC; Moerland MA; Eisbruch A; Terhaard CH
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):449-53. PubMed ID: 20056347
[TBL] [Abstract][Full Text] [Related]
19. Level II lymph nodes and radiation-induced xerostomia.
Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
[TBL] [Abstract][Full Text] [Related]
20. Anatomical and dose changes of gross tumour volume and parotid glands for head and neck cancer patients during intensity-modulated radiotherapy: effect on the probability of xerostomia incidence.
Marzi S; Pinnarò P; D'Alessio D; Strigari L; Bruzzaniti V; Giordano C; Giovinazzo G; Marucci L
Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):e54-62. PubMed ID: 22138192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]